Boston Scientific announces positive results from its Champion-Af study
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
The study evaluated the performance of the Watchman Flx™ left atrial appendage occluder as a first-line therapy for reducing stroke risk. Research data show that the Watchman Flx™ device met all predefined primary safety endpoints and primary efficacy endpoints. At the same time, all secondary safety and efficacy endpoints were also successfully achieved. These results indicate that, as a first-line therapy, the device demonstrates excellent safety and efficacy, offering an important new option for stroke prevention.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Asset management institution: Japanese long-term bonds are attractive
金十•2026/06/26 10:50
Arm Holdings drops over 5% in U.S. pre-market trading
金色财经•2026/06/26 10:47
Trending news
MoreCrypto prices
MoreBitcoin
BTC
$59,288.04
-3.21%
Ethereum
ETH
$1,547.08
-5.33%
Tether USDt
USDT
$0.9985
+0.00%
USDC
USDC
$0.9996
-0.01%
XRP
XRP
$1.03
-4.42%
Solana
SOL
$68.84
+0.92%
TRON
TRX
$0.3218
-2.03%
Hyperliquid
HYPE
$62.06
-1.65%
Dogecoin
DOGE
$0.07364
-3.29%
Zcash
ZEC
$396.24
-3.93%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now